The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 31, 2026
Snapshot (as of Aug 31, 2026): Amgen Inc. (AMGN) pays a $9.94 annual dividend ($2.52 quarterly), yielding 2.30% at $432.42/share. Next ex-dividend date 2026-08-21. 13+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.30%
Annual Dividend: $9.94 per share
Payout Ratio: 60.4%
Ex-Dividend Date: 2026-08-21
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 16
Amgen Inc. dividend income comes from one of biotechnology's largest companies, built on a portfolio spanning oncology, cardiovascular disease, and inflammatory conditions, with products like Repatha, Enbrel, and Prolia serving patients worldwide. AMGN currently pays a 2.3% dividend yield. Shareholders receive $9.94 per share annually in quarterly payments, with the next ex-dividend date on August 21, 2026. A beta of 0.413 means AMGN stock moves far less than the broader market, which suits income investors who prioritize low volatility over maximum yield.
Amgen Inc. pays out 60.4% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a broad product lineup serving recurring medical needs, from anemia treatment with Aranesp to osteoporosis prevention with Prolia, categories where patient demand does not disappear in economic downturns. Amgen Inc. dividend safety faces its most visible pressure from that payout ratio itself: at 60.4%, there is less room to absorb an earnings decline before the dividend would require reassessment.
Over the past 13 years, Amgen Inc. has grown its dividend at 15.6% per year. Per-share payments climbed from $1.44 in 2012 to $9.52 in 2025 (2026 is a partial year and excluded from this calculation). The smallest annual increase in the window was 5.6% in 2024, a notable step down from the double-digit rates that defined most of the Amgen Inc. dividend history.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.1% | $7.76 (2022) | $9.52 (2025) |
| 5-Year | +8.3% | $6.40 (2020) | $9.52 (2025) |
| 10-Year | +11.7% | $3.16 (2015) | $9.52 (2025) |
AMGN fits dividend investors who want meaningful per-share income from a large biotechnology business, paired with a long growth streak. The current yield of 2.3% sits above the 5-year average of 1.94%, which means today's entry point delivers more income than the historical norm. The trade-off is a moderate (2–4%) yield that will not satisfy investors chasing high income, and a payout ratio at the elevated end that leaves a narrower cushion than lower-payout peers. What investors get is 13 consecutive years of increases and a 15.6% CAGR over the full history window. What they accept is slower recent growth, with 2024's increase coming in at just 5.6%.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-21 | $2.5200 |
| 2026-05-15 | $2.5200 |
| 2026-02-13 | $2.5200 |
| 2025-11-21 | $2.3800 |
| 2025-08-22 | $2.3800 |
| 2025-05-16 | $2.3800 |
| 2025-02-14 | $2.3800 |
| 2024-11-18 | $2.2500 |
| 2024-08-16 | $2.2500 |
| 2024-05-16 | $2.2500 |
| Year | Total Dividends |
|---|---|
| 2026 | $7.5600 |
| 2025 | $9.5200 |
| 2024 | $9.0000 |
| 2023 | $8.5200 |
| 2022 | $7.7600 |
Project income from AMGN with the AMGN dividend calculator or track your full portfolio with the dividend tracker.